These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 7473815

  • 1. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.
    Kalemkerian GP, Slusher R, Ramalingam S, Gadgeel S, Mabry M.
    J Natl Cancer Inst; 1995 Nov 15; 87(22):1674-80. PubMed ID: 7473815
    [Abstract] [Full Text] [Related]

  • 2. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
    Ohlmann CH, Jung C, Jaques G.
    Int J Cancer; 2002 Aug 10; 100(5):520-6. PubMed ID: 12124800
    [Abstract] [Full Text] [Related]

  • 3. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines.
    Scher RL, Saito W, Dodge RK, Richtsmeier WJ, Fine RL.
    Otolaryngol Head Neck Surg; 1998 Apr 10; 118(4):464-71. PubMed ID: 9560096
    [Abstract] [Full Text] [Related]

  • 4. The neurotoxin 1-methyl-4-phenylpyridinium: a selective cytostatic agent in small-cell lung cancer cell lines with neuroendocrine properties.
    Marini AM, Fridman R, Kanemoto T, Martin GR, Guo Y, Passaniti A.
    J Natl Cancer Inst; 1992 Oct 21; 84(20):1582-7. PubMed ID: 1328660
    [Abstract] [Full Text] [Related]

  • 5. Activity of fenretinide plus chemotherapeutic agents in small-cell lung cancer cell lines.
    Kalemkerian GP, Ou X.
    Cancer Chemother Pharmacol; 1999 Oct 21; 43(2):145-50. PubMed ID: 9923820
    [Abstract] [Full Text] [Related]

  • 6. Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell lines.
    Ali MA, Rosati R, Pettit GR, Kalemkerian GP.
    Anticancer Res; 1998 Oct 21; 18(2A):1021-6. PubMed ID: 9615758
    [Abstract] [Full Text] [Related]

  • 7. Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: induction of apoptosis and bcl-2 modification.
    Kalemkerian GP, Ou X, Adil MR, Rosati R, Khoulani MM, Madan SK, Pettit GR.
    Cancer Chemother Pharmacol; 1999 Oct 21; 43(6):507-15. PubMed ID: 10321512
    [Abstract] [Full Text] [Related]

  • 8. Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)retinamide.
    Di Vinci A, Geido E, Infusini E, Giaretti W.
    Int J Cancer; 1994 Nov 01; 59(3):422-6. PubMed ID: 7927952
    [Abstract] [Full Text] [Related]

  • 9. N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL).
    Faderl S, Lotan R, Kantarjian HM, Harris D, Van Q, Estrov Z.
    Leuk Res; 2003 Mar 01; 27(3):259-66. PubMed ID: 12537979
    [Abstract] [Full Text] [Related]

  • 10. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
    Wang WL, Healy ME, Sattler M, Verma S, Lin J, Maulik G, Stiles CD, Griffin JD, Johnson BE, Salgia R.
    Oncogene; 2000 Jul 20; 19(31):3521-8. PubMed ID: 10918610
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
    Ponzoni M, Bocca P, Chiesa V, Decensi A, Pistoia V, Raffaghello L, Rozzo C, Montaldo PG.
    Cancer Res; 1995 Feb 15; 55(4):853-61. PubMed ID: 7850799
    [Abstract] [Full Text] [Related]

  • 12. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
    Delia D, Aiello A, Lombardi L, Pelicci PG, Grignani F, Grignani F, Formelli F, Menard S, Costa A, Veronesi U.
    Cancer Res; 1993 Dec 15; 53(24):6036-41. PubMed ID: 8261419
    [Abstract] [Full Text] [Related]

  • 13. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma.
    Sheikh MS, Shao ZM, Li XS, Ordonez JV, Conley BA, Wu S, Dawson MI, Han QX, Chao WR, Quick T.
    Carcinogenesis; 1995 Oct 15; 16(10):2477-86. PubMed ID: 7586155
    [Abstract] [Full Text] [Related]

  • 14. Corticotropin-releasing factor receptors in human small cell lung carcinoma cells: radioligand binding, second messenger, and northern blot analysis data.
    Dieterich KD, Grigoriadis DE, De Souza EB.
    Endocrinology; 1994 Oct 15; 135(4):1551-8. PubMed ID: 7925116
    [Abstract] [Full Text] [Related]

  • 15. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.
    Maurer BJ, Metelitsa LS, Seeger RC, Cabot MC, Reynolds CP.
    J Natl Cancer Inst; 1999 Jul 07; 91(13):1138-46. PubMed ID: 10393722
    [Abstract] [Full Text] [Related]

  • 16. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide in glioma cells.
    Saitoh Y, Goto T, Puduvalli VK, Murakami M, Kochi M, Levin VA, Kyritsis AP, Ushio Y.
    Int J Oncol; 1999 Sep 07; 15(3):499-504. PubMed ID: 10427131
    [Abstract] [Full Text] [Related]

  • 17. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
    Ziegler A, Luedke GH, Fabbro D, Altmann KH, Stahel RA, Zangemeister-Wittke U.
    J Natl Cancer Inst; 1997 Jul 16; 89(14):1027-36. PubMed ID: 9230884
    [Abstract] [Full Text] [Related]

  • 18. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.
    Roberson KM, Penland SN, Padilla GM, Selvan RS, Kim CS, Fine RL, Robertson CN.
    Cell Growth Differ; 1997 Jan 16; 8(1):101-11. PubMed ID: 8993839
    [Abstract] [Full Text] [Related]

  • 19. Mechanistic studies of the effects of the retinoid N-(4-hydroxyphenyl)retinamide on prostate cancer cell growth and apoptosis.
    Shen JC, Wang TT, Chang S, Hursting SD.
    Mol Carcinog; 1999 Mar 16; 24(3):160-8. PubMed ID: 10204800
    [Abstract] [Full Text] [Related]

  • 20. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
    Shishodia S, Gutierrez AM, Lotan R, Aggarwal BB.
    Cancer Res; 2005 Oct 15; 65(20):9555-65. PubMed ID: 16230421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.